Researchers report experimental drug may prolong survival in ALS patients
Trial drug combination shows potential to prolong survival of ALS patients by more than six months.
Trial drug combination shows potential to prolong survival of ALS patients by more than six months.
On Oct. 30 at 2pm, Dr. Melissa Armstrong will discuss Alzheimer's disease with a special focus on Lewy body dementia.
A free event for caregivers and the community from Oct. 20-22. Includes live online presentations, daily sessions from 10am-4pm and a virtual expo hall.
UF researchers team up with international partners to improve understanding and treatment of two rare hereditary neuromuscular disorders.
Yuqing Li and Dr. Yuning Liu’s findings published in the journal Brain Research Bulletin.
Yuqing Li and Dr. Yuning Liu’s findings published in the journal Brain Research Bulletin.
Study uncovers research areas considered most pressing by patients and caretakers.
Join our team to raise awareness and funds for Alzheimer’s care, support and research.
View a recording of Drs. Todd Golde and Steven DeKosky’s UF Health Webinar.
Researchers will evaluate the impact of in-vehicle technologies.